CytOSorb TreatMent Of Critically Ill PatientS Registry
Recruiting
Observational Study
Septic Shock
Acute Respiratory Distress Syndrome
Trauma
Rhabdomyolysis
Cardiogenic Shock
Pancreatitis
Acute on Chronic Liver Failure
Acute Liver Failure
Burns
Chimeric Antigen Receptor T-Cell Therapy (CAR-T) Cytokine Release Syndrome (CRS)
Extracorporeal Life Support
Postoperative Endocarditis
Hemophagocytic Lymphohistiocytoses
Liver Transplant; Complications
Infectious Disease
Postoperative Vasoplegic Syndrome
Drug Overdose
Sepsis
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 3,000 (estimated)
- Sponsor
- CytoSorbents, Inc · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Registry intended to provide a data repository and reporting infrastructure for the surveillance of CytoSorb device use in real-world critical care settings, and to serve as an objective, comprehensive, and scientifically-based resource to measure and improve the quality of patient care
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Planned OR actual CytoSorb® 300 mL device utilization
2. Informed consent for prospective registry participation
Exclusion Criteria:
1. Use of the CytoSorb® 300 mL device for antithrombotic removal only
2. Intraoperative use of CytoSorb® 300 mL device during cardiac surgery…
Contacts